BIODESIX, INC. Other Non-Current Liabilities
BIODESIX, INC. (BDSX) had Other Non-Current Liabilities of $704.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-05
- 2026-06-30: Other Liabilities, Noncurrent $704.00K.
- 2026-03-31: Other Liabilities, Noncurrent $860.00K.
- 2025-12-31: Other Liabilities, Noncurrent $1.02M.
- 2025-09-30: Other Liabilities, Noncurrent $769.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $704.00K 10-Q · filed 2026-08-05 |
| 2026-03-31 | $860.00K 10-Q · filed 2026-05-04 |
| 2025-12-31 | $1.02M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $769.00K 10-Q · filed 2025-11-03 |
| 2025-06-30 | $549.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $692.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $815.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $620.00K 10-Q · filed 2024-11-01 |
| 2024-06-30 | $744.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $615.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $712.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | $815.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $896.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $648.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $558.00K 10-K · filed 2024-03-01 |
| 2022-09-30 | $60.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $70.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $615.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $1.39M 10-K · filed 2023-03-06 |
| 2021-09-30 | $1.48M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.59M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $1.69M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $1.92M 10-K · filed 2022-03-14 |
| 2020-09-30 | $392.00K 10-Q · filed 2020-12-10 |
| 2019-12-31 | $358.00K 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |